Work

Use of Pristinamycin for Macrolide-ResistantMycoplasma genitaliumInfection

Year: 2018

Type: article

Abstract: increase in bacterial load. Gastrointestinal side effects occurred in 7% of patients. Pristinamycin at maximum oral dose, or combined with doxycycline, cured 75% of macrolide-resistant M. genitalium infections. Pristinamycin is well-tolerated and remains an option where fluoroquinolones have failed or cannot be used.

Source: Emerging infectious diseases

DOI: 10.3201/eid2402.170902

Authors: Tim R.H. Read, Jørgen S. Jensen, Christopher K. Fairley, Mieken Grant, Jennifer A. Danielewski, Jenny Su, Gerald L. Murray, Eric P.F. Chow, Karen Worthington, Suzanne M. Garland, Sepehr N. Tabrizi, Catriona S. Bradshaw

Institutions: Statens Serum Institut, Royal Women's Hospital, The University of Melbourne, The Alfred Hospital, Melbourne Sexual Health Centre, Murdoch Children's Research Institute, Alfred Health, Monash University

Language: English

Topic: Reproductive tract infections research

Subfield: Microbiology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: diamond

Funders: Medical Research Council, National Health and Medical Research Council

Awards: Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination, A randomised trial of allowing men who have sex with men to have HIV and syphilis tests between clinic consultations.

OpenAlex ID: W2781940573

FWCI: 6.385

Cites: 33

Cited by: 95

Related to: 10